Приказ основних података о документу

dc.creatorBrajić, Ivana
dc.creatorSkodrić, Sanja
dc.creatorMilenković, S.
dc.creatorTepavčević, Zvezdana
dc.creatorSoldatović, Ivan
dc.creatorČolić, Snježana
dc.creatorMilašin, Jelena
dc.creatorAndrić, Miroslav
dc.date.accessioned2020-07-02T13:06:19Z
dc.date.available2020-07-02T13:06:19Z
dc.date.issued2016
dc.identifier.issn1354-523X
dc.identifier.urihttps://smile.stomf.bg.ac.rs/handle/123456789/2140
dc.description.abstractObjectivesThe aim of this study was to investigate survivin, cyclin D1, and p21hras expression in keratocystic odontogenic tumors before and after decompression, as well as in pericoronal follicles. A potential correlation between the expression levels of these proteins was also investigated. Materials and methodsWe analyzed eighteen keratocystic tumors treated by decompression and subsequent enucleation along with seven pericoronal follicles using immunohistochemistry. ResultsKeratocystic tumor samples, both before and after decompression, were positive for each of the investigated proteins. In pericoronal follicles, survivin exhibited cytoplasmic staining in contrast to nuclear staining in keratocystic tumors. Cyclin D1 expression was negative in pericoronal follicles, and p21hras expression was similar in both groups. Survivin showed significantly higher expression after decompression, while cyclin D1 and p21hras remained unchanged (P=0.039, P=0.255, P=0.913, respectively). There was no correlation between these proteins neither before nor after decompression. ConclusionsWithin the limits of the study, we can conclude that following decompression, keratocystic odontogenic tumors preserve distinct immunohistochemical profiles of cyclin D1 and p21hras expression, despite substantial reduction in size of the lesions. Significant increase of survivin expression after decompression might be attributed to higher level of epithelial proliferation caused by this procedure.en
dc.publisherWiley-Blackwell, Hoboken
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175075/RS//
dc.rightsrestrictedAccess
dc.sourceOral Diseases
dc.subjectsurvivinen
dc.subjectcyclin D1en
dc.subjectp21hrasen
dc.subjectkeratocystic odontogenic tumoren
dc.subjectdecompressionen
dc.titleSurvivin, cyclin D1, and p21hras in keratocystic odontogenic tumors before and after decompressionen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractМилашин, Јелена; Миленковић, С.; Чолић, Сњежана; Скодрић, Сања; Тепавчевић, Звездана; Солдатовић, Иван; Aндрић, Мирослав; Брајић, Ивана;
dc.citation.volume22
dc.citation.issue3
dc.citation.spage220
dc.citation.epage225
dc.citation.other22(3): 220-225
dc.citation.rankM22
dc.identifier.wos000372354400010
dc.identifier.doi10.1111/odi.12414
dc.identifier.pmid26662564
dc.identifier.scopus2-s2.0-84959352731
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу